DANIELLE DONLAN: Open Payments
NPI 1255983888 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 23 payments from 14 companies in 2025. Trend: 2023 $237 · 2024 $450 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC | 2 | $67 |
| PFIZER INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $42 |
| Cleerly, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $31 |
| BETA BIONICS, INC. | 1 | $31 |
| Abbott Laboratories | 1 | $30 |
Products named: Ambulatory Monitoring & Diagnostics Undivided, REXULTI, CAPVAXIVE, Cleerly Ischemia, MOUNJARO, iLet Bionic Pancreas, FREESTYLE LIBRE 3, Flucelvax.
Industry payments across CO — which companies pay providers there.
